Breaking News Instant updates and real-time market news.

USX

U.S. Xpress Enterprises

$9.74 /

-0.5 (-4.88%)

16:15
04/22/21
04/22
16:15
04/22/21
16:15

U.S. Xpress Enterprises reports Q1 EPS 5c, consensus 5c

Reports Q1 revenue $450.8M, consensus $449.11M. Eric Fuller, President and CEO, commented, "I am pleased with our team's continued execution of our digital initiatives, which are designed to support our goal of doubling our revenues over the next four years. Notably, we grew Variant to 11.8% of Truckload revenues in the first quarter, compared to 9.4% in the fourth quarter of 2020, and remain on track to meet or exceed our goal of reaching 1,500 Variant tractors, generating approximately 25% of Truckload revenues, by the end of 2021. We also made strong gains in our Brokerage segment as we processed 67% of our Brokerage transactions digitally in the first quarter. Our digital platform is enabling our Brokerage segment to profitably scale while offering freight selectivity for Variant."

  • 22

    Apr

  • 26

    May

USX U.S. Xpress Enterprises
$9.74 /

-0.5 (-4.88%)

03/31/21 Morgan Stanley
U.S. Xpress Enterprises price target raised to $15 from $13 at Morgan Stanley
03/31/21 Stephens
U.S. Xpress Enterprises downgraded to Equal Weight at Stephens following rally
03/31/21 Stephens
U.S. Xpress Enterprises downgraded to Equal Weight from Overweight at Stephens
03/04/21 BofA
U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA

TODAY'S FREE FLY STORIES

Earnings
Evergy backs FY21 adjusted EPS view $3.20-$3.40, consensus $3.29 » 07:58
05/06/21
05/06
07:58
05/06/21
07:58
EVRG

Evergy

$63.48 /

-0.735 (-1.14%)

Sees long-term adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

04/19/21 Wolfe Research
Evergy upgraded to Outperform from Peer Perform at Wolfe Research
04/14/21 Wells Fargo
Evergy price target raised to $67 from $60 at Wells Fargo
04/06/21 Craig-Hallum
Craig-Hallum reiterates Buy on Anterix as Evergy reveals plans for 900 MHz
10/15/20
Fly Intel: Top five analyst upgrades
EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

Recommendations
Digi International price target lowered to $25 from $28 at Canaccord » 07:58
05/06/21
05/06
07:58
05/06/21
07:58
DGII

Digi International

$17.88 /

+ (+0.00%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGII Digi International
$17.88 /

+ (+0.00%)

DGII Digi International
$17.88 /

+ (+0.00%)

03/09/21 Piper Sandler
Digi International initiated with an Overweight at Piper Sandler
02/04/21 Roth Capital
Digi International price target raised to $29 from $22 at Roth Capital
02/04/21 Lake Street
Digi International price target raised to $25 from $21 at Lake Street
02/04/21 Craig-Hallum
Digi International price target raised to $28 from $22 at Craig-Hallum
DGII Digi International
$17.88 /

+ (+0.00%)

  • 04
    Mar
DGII Digi International
$17.88 /

+ (+0.00%)

Hot Stocks
Corvus Gold receives $20M loan from AngloGold Ashanti North America » 07:57
05/06/21
05/06
07:57
05/06/21
07:57
KOR

Corvus Gold

$2.08 /

-0.01 (-0.48%)

, AU

AngloGold Ashanti

$21.54 /

+0.195 (+0.91%)

Corvus Gold (KOR)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOR Corvus Gold
$2.08 /

-0.01 (-0.48%)

AU AngloGold Ashanti
$21.54 /

+0.195 (+0.91%)

KOR Corvus Gold
$2.08 /

-0.01 (-0.48%)

04/15/21 BMO Capital
Corvus Gold initiated with an Outperform at BMO Capital
AU AngloGold Ashanti
$21.54 /

+0.195 (+0.91%)

03/24/21 Morgan Stanley
AngloGold Ashanti downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/21 Renaissance Capital
AngloGold Ashanti upgraded to Buy from Hold at Renaissance Capital
03/08/21 HSBC
AngloGold Ashanti upgraded to Hold from Reduce at HSBC
02/22/21 RBC Capital
AngloGold Ashanti downgraded to Sector Perform from Outperform at RBC Capital
AU AngloGold Ashanti
$21.54 /

+0.195 (+0.91%)

Hot Stocks
uniQure receives $450M in commercialization, license agreement with CSL Behring » 07:57
05/06/21
05/06
07:57
05/06/21
07:57
QURE

uniQure

$30.43 /

-0.54 (-1.74%)

CSL Behring announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$30.43 /

-0.54 (-1.74%)

QURE uniQure
$30.43 /

-0.54 (-1.74%)

04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
QURE uniQure
$30.43 /

-0.54 (-1.74%)

QURE uniQure
$30.43 /

-0.54 (-1.74%)

Earnings
Gogo reports Q1 EPS (9c), consensus (13c) » 07:57
05/06/21
05/06
07:57
05/06/21
07:57
GOGO

Gogo

$9.89 /

-0.635 (-6.03%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOGO Gogo
$9.89 /

-0.635 (-6.03%)

GOGO Gogo
$9.89 /

-0.635 (-6.03%)

04/22/21 William Blair
Gogo lowered annual interest expensive by 64%, says William Blair
04/08/21 Cowen
Gogo upgraded to Outperform from Market Perform at Cowen
04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
04/04/21 William Blair
Gogo upgraded to Outperform from Market Perform at William Blair
GOGO Gogo
$9.89 /

-0.635 (-6.03%)

GOGO Gogo
$9.89 /

-0.635 (-6.03%)

GOGO Gogo
$9.89 /

-0.635 (-6.03%)

Hot Stocks
CVS Health to administer no-cost COVID-19 vaccines at 19 locations in NH » 07:56
05/06/21
05/06
07:56
05/06/21
07:56
CVS

CVS Health

$83.10 /

+2.04 (+2.52%)

In an ongoing effort to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$83.10 /

+2.04 (+2.52%)

CVS CVS Health
$83.10 /

+2.04 (+2.52%)

07:33 Today BMO Capital
CVS Health price target raised to $90 from $82 at BMO Capital
05/05/21 Jefferies
CVS Health price target raised to $95 from $90 at Jefferies
05/05/21 RBC Capital
CVS Health price target raised to $91 from $80 at RBC Capital
05/05/21 Citi
CVS Health price target raised to $98 from $83 at Citi
CVS CVS Health
$83.10 /

+2.04 (+2.52%)

CVS CVS Health
$83.10 /

+2.04 (+2.52%)

CVS CVS Health
$83.10 /

+2.04 (+2.52%)

CVS CVS Health
$83.10 /

+2.04 (+2.52%)

Upgrade
Tokio Marine Holdings upgraded to Buy from Hold at Jefferies » 07:56
05/06/21
05/06
07:56
05/06/21
07:56
TKOMY

Tokio Marine Holdings

$48.31 /

+0.16 (+0.33%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TKOMY Tokio Marine Holdings
$48.31 /

+0.16 (+0.33%)

10/19/20 Goldman Sachs
Tokio Marine Holdings downgraded to Buy from Conviction Buy at Goldman Sachs
Earnings
Evergy reports Q1 adjusted EPS 55c, consensus 48c » 07:56
05/06/21
05/06
07:56
05/06/21
07:56
EVRG

Evergy

$63.48 /

-0.735 (-1.14%)

"We are off to a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

04/19/21 Wolfe Research
Evergy upgraded to Outperform from Peer Perform at Wolfe Research
04/14/21 Wells Fargo
Evergy price target raised to $67 from $60 at Wells Fargo
04/06/21 Craig-Hallum
Craig-Hallum reiterates Buy on Anterix as Evergy reveals plans for 900 MHz
10/15/20
Fly Intel: Top five analyst upgrades
EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

EVRG Evergy
$63.48 /

-0.735 (-1.14%)

Earnings
Madrigal Pharmaceuticals reports Q1 EPS ($3.32), consensus ($3.85) » 07:55
05/06/21
05/06
07:55
05/06/21
07:55
MDGL

Madrigal Pharmaceuticals

$129.25 /

-1.2 (-0.92%)

As of March 31, Madrigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDGL Madrigal Pharmaceuticals
$129.25 /

-1.2 (-0.92%)

MDGL Madrigal Pharmaceuticals
$129.25 /

-1.2 (-0.92%)

03/02/21 Oppenheimer
Madrigal Pharmaceuticals price target lowered to $190 from $200 at Oppenheimer
02/25/21 Piper Sandler
Piper Sandler 'impressed' with Madrigal progress in enrolling MAESTRO-NASH
11/23/20 Evercore ISI
Madrigal Pharmaceuticals resumed with an Outperform at Evercore ISI
11/06/20 Goldman Sachs
Madrigal Pharmaceuticals price target raised to $126 from $118 at Goldman Sachs
MDGL Madrigal Pharmaceuticals
$129.25 /

-1.2 (-0.92%)

MDGL Madrigal Pharmaceuticals
$129.25 /

-1.2 (-0.92%)

Hot Stocks
Profound Medical, Akumin enter in U.S. agreement for TULSA-PRO » 07:54
05/06/21
05/06
07:54
05/06/21
07:54
PROF

Profound Medical

$18.26 /

-0.04 (-0.22%)

, AKU

Akumin

$2.96 /

+0.01 (+0.34%)

Profound Medical (PROF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PROF Profound Medical
$18.26 /

-0.04 (-0.22%)

AKU Akumin
$2.96 /

+0.01 (+0.34%)

PROF Profound Medical
$18.26 /

-0.04 (-0.22%)

03/03/21 Alliance Global Partners
Alliance Global still bullish on Profound Medical after 'mixed' Q4
01/25/21 Lake Street
Profound Medical price target raised to $32 from $27 at Lake Street
01/07/21 Alliance Global Partners
Profound Medical price target raised to $28.25 from $20.25 at Alliance Global
09/15/20 Jefferies
Profound Medical initiated with a Buy at Jefferies
AKU Akumin
$2.96 /

+0.01 (+0.34%)

09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
  • 16
    Jul
Earnings
Agenus reports Q1 EPS (27c), consensus (31c) » 07:54
05/06/21
05/06
07:54
05/06/21
07:54
AGEN

Agenus

$2.95 /

-0.025 (-0.84%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGEN Agenus
$2.95 /

-0.025 (-0.84%)

AGEN Agenus
$2.95 /

-0.025 (-0.84%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley FBR
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
AGEN Agenus
$2.95 /

-0.025 (-0.84%)

Hot Stocks
Luokung Technology announces favorable ruling granting preliminary injunction » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
LKCO

Luokung Technology

$1.48 /

-0.14 (-8.64%)

Luokung Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKCO Luokung Technology
$1.48 /

-0.14 (-8.64%)

LKCO Luokung Technology
$1.48 /

-0.14 (-8.64%)

Earnings
CarMax targets FY26 revenue $33B » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
KMX

CarMax

$137.85 /

+0.535 (+0.39%)

Expects to grow national…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

05/03/21 Evercore ISI
CarMax added to Tactical Outperform list at Evercore ISI
04/09/21 Oppenheimer
CarMax price target raised to $153 from $130 at Oppenheimer
04/05/21 Evercore ISI
CarMax pullback an attractive entry opportunity, says Evercore ISI
04/05/21 Stephens
CarMax price target raised to $154 from $130 at Stephens
KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

KMX CarMax
$137.85 /

+0.535 (+0.39%)

Earnings
Adient reports Q1 adjusted EPS $1.13, consensus 56c » 07:53
05/06/21
05/06
07:53
05/06/21
07:53
ADNT

Adient

$46.99 /

+1.345 (+2.95%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

03/25/21 Wells Fargo
Adient initiated with an Overweight at Wells Fargo
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
Adient downgraded to Underweight on long-term industry risk at Morgan Stanley
03/17/21 Morgan Stanley
Adient downgraded to Underweight from Equal Weight at Morgan Stanley
ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

ADNT Adient
$46.99 /

+1.345 (+2.95%)

Hot Stocks
Palantir announces extended commitment from U.S. Coast Guard » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
PLTR

Palantir

$21.17 /

-0.46 (-2.13%)

Palantir Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

04/22/21 Wolfe Research
Palantir initiated with a Peer Perform at Wolfe Research
03/15/21 Credit Suisse
Palantir assumed with an Underperform at Credit Suisse
02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

PLTR Palantir
$21.17 /

-0.46 (-2.13%)

Earnings
Protara Therapeutics reports Q1 EPS ($1.20), consensus (73c) » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
TARA

Protara Therapeutics

$10.30 /

-0.08 (-0.77%)

"We remain on track…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Guggenheim
Protara Therapeutics started with Buy rating, $50 target at Guggenheim
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

  • 22
    Sep
TARA Protara Therapeutics
$10.30 /

-0.08 (-0.77%)

Hot Stocks
Mogo in partnership with Tom Lee's Fundstrat for crypto research » 07:52
05/06/21
05/06
07:52
05/06/21
07:52
MOGO

Mogo

$8.16 /

-0.02 (-0.24%)

Mogo announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

MOGO Mogo
$8.16 /

-0.02 (-0.24%)

03/24/21 Canaccord
Mogo price target raised to C$14 from C$13 at Canaccord
03/23/21 H.C. Wainwright
Outlook, Moka deal should 'drive excitement' about Mogo, says H.C. Wainwright
03/01/21 H.C. Wainwright
Mogo price target raised to $16 from $4 at H.C. Wainwright
02/11/21 Canaccord
Mogo downgraded to Hold from Speculative Buy at Canaccord
MOGO Mogo
$8.16 /

-0.02 (-0.24%)

Upgrade
Jefferies upgrades Mercury Systems, sees growth intact despite disappointing Q3 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
MRCY

Mercury Systems

$57.72 /

-12.47 (-17.77%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

05:11 Today Jefferies
Mercury Systems upgraded to Buy from Hold at Jefferies
05/05/21
Fly Intel: Top five analyst downgrades
05/05/21 Canaccord
Canaccord downgrades Mercury Systems on lower growth outlook
05/05/21 Canaccord
Mercury Systems downgraded to Hold from Buy at Canaccord
MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

MRCY Mercury Systems
$57.72 /

-12.47 (-17.77%)

Hot Stocks
Adaptimmune expects cash to fund operations into early 2023 » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

The Company believes that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
CECO Environmental reports Q1 adjusted EPS 9c, consensus 9c » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
CECE

CECO Environmental

$7.47 /

+0.08 (+1.08%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

CECE CECO Environmental
$7.47 /

+0.08 (+1.08%)

03/04/21 H.C. Wainwright
CECO Environmental price target raised to $15 from $9 at H.C. Wainwright
Earnings
Adaptimmune reports Q1 EPS (4c), consensus (25c) » 07:51
05/06/21
05/06
07:51
05/06/21
07:51
ADAP

Adaptimmune

$5.11 /

-0.22 (-4.13%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
ADAP Adaptimmune
$5.11 /

-0.22 (-4.13%)

  • 02
    Jun
Earnings
Laureate Education reaffirms FY21 revenue $1B-$1.04B, two estimates $1B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
LAUR

Laureate Education

$13.37 /

-0.16 (-1.18%)

Sees FY21 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

09/15/20 Barclays
Laureate Education price target raised to $14 from $11 at Barclays
09/11/20 Stifel
Laureate Education's Walden sale proceeds less than expected, says Stifel
06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
LAUR Laureate Education
$13.37 /

-0.16 (-1.18%)

Hot Stocks
EQT Corporation to acquire membership interests in Alta subsidiaries for $2.93B » 07:50
05/06/21
05/06
07:50
05/06/21
07:50
EQT

EQT Corporation

$20.19 /

+0.28 (+1.41%)

EQT Corporation announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

03/23/21 Goldman Sachs
EQT Corporation assumed with a Buy at Goldman Sachs
03/15/21 Piper Sandler
EQT Corporation price target raised to $22 from $18 at Piper Sandler
02/18/21 TD Securities
EQT Corporation price target raised to $24 from $20 at TD Securities
01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

  • 28
    Oct
EQT EQT Corporation
$20.19 /

+0.28 (+1.41%)

Earnings
Black Knight raises FY21 adjusted EPS view to $2.16-$2.24 from $2.11-$2.22 » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
BKI

Black Knight

$71.42 /

-1.73 (-2.37%)

FY21 consensus $2.20.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

BKI Black Knight
$71.42 /

-1.73 (-2.37%)

04/19/21 Barclays
Black Knight shares nearing 'conviction buy levels,' says Barclays
04/13/21
Fly Intel: Top five analyst initiations
04/13/21 Raymond James
Black Knight initiated with a Market Perform at Raymond James
02/17/21 Susquehanna
Susquehanna upgrades Black Knight to Positive as growth resumes
BKI Black Knight
$71.42 /

-1.73 (-2.37%)

  • 17
    Jun
Earnings
Ranpak Holdings reports Q1 EPS 8c, consensus (2c) » 07:49
05/06/21
05/06
07:49
05/06/21
07:49
PACK

Ranpak Holdings

$20.13 /

+0.445 (+2.26%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

04/26/21 Berenberg
Ranpak Holdings initiated with a Buy at Berenberg
04/19/21 Sidoti
Ranpak Holdings initiated with a Buy at Sidoti
PACK Ranpak Holdings
$20.13 /

+0.445 (+2.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.